Posts Tagged ‘steroid theraphy’
Impact of anti-inflammatory agents
The combination of inhaled steroids with long-acting beta-2-agonists (fluticasone + salmeterol;seretide)has been demonstrated to achieve a42 percent reduction in the rate of exacerbations requiring oralcorticosteroids, as compared to placebo (p<0.001) (figure 2).
in addition, combination therapy reduces several’s inflammatory cells and cytokines with a resultant decrease in the inflammation associated with COPD. Read the rest of this entry »